Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
| |
 |
Articles |
|
|
Advances in disease research from single cell proteomics.
Microheterogeneity in seemingly homogenous cell populations plays a key role in determining the pathways pursued by biological systems. Variation in expression of gene products and other processes result in this underlying microheterogeneity.
|
|
|
| |
| |
| |
|
|
Early-stage fill finish: Preparing for a clinical batch.
For biopharmaceutical companies developing an injectable drug product, the transition from laboratory to in-human trials is one of the most important steps in their molecule's early development....
|
|
| |
 |
News |
|
|
Indian Pharma Must Aim Generics - Commerce Industry Minister.
To become self-reliant, Union Commerce and Industry Minister of India, Piyush Goyal advised the domestic pharmaceutical sector to develop its generic medicine segment and provide greater synergy between input and output of products. Goyal, speaking at an event ...
|
|
 |
| | |
| |
| |
|
|
China Ticks BeiGene PD-1, Can Novartis Bloom In US, Europe.
Last year, Novartis chose to purchase its way into the arena after the failure of its PD-1/L1 candidate, spartalizumab. So it reached a deal with China's BeiGene, paying $650 million up front and promising $1.55 billion in milestone payments in exchange...
|
|
|
| |
|
Sanofi Starts Work On €400 Million Smart Space In Singapore.
Sanofi’s factory of the future in Singapore could be operational by the middle of the decade. One of two so called Evolutive Vaccine Facilities that the French drugmaker is building with a collective investment...
|
|
 |
| |
| |
| |
|
|
FDA Wants To Know How Patients, Doctors Decide Prescriptions.
The FDA's Office of Prescription Medicine Promotion intends to know how patients and doctors consider the risks and benefits of a new prescription medicine before starting it. What factors influence treatment decisions, and how do people choose...
|
|
|
| |
|
200M COVID Jab Left Over Doses Leads SII Halting Production.
As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world's largest vaccine manufacturer's warehouses. As per Bloomberg, Serum Institute of India CEO Adar Poonawalla revealed at the India Economic...
|
|
 |
|
|
